BSX · 8-K · 20260729PR000051
Stock Repurchase Program
BOSTON SCIENTIFIC CORP · 2026-07-29 · Importance 69 · Surprise 50 · In source text
Boston Scientific completed its previously announced $2 billion accelerated share repurchase program during the second quarter. The program repurchased approximately 40 million shares. Diluted weighted-average shares declined to 1,474.8 million from 1,493.5 million year over year. GAAP diluted EPS increased to $0.61 from $0.53, while adjusted EPS rose to $0.86 from $0.75.
Key facts
- Completed the previously announced $2 billion accelerated share repurchase program, repurchasing approximately 40 million shares. source
- Weighted-average diluted shares outstanding for the three months ended June 30, 2026: 1,474.8 million shares. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | — | Completed the previously announced $2 billion accelerated share repurchase program, repurchasing approximately 40 million shares. |